Logo 142 Pill - white oval, 12mm
Pill with imprint Logo 142 is White, Oval and has been identified as Divalproex Sodium Delayed Release 125 mg. It is supplied by Actavis.
Divalproex sodium is used in the treatment of Bipolar Disorder; Mania; Migraine Prevention; Seizures; Epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 142
Divalproex Sodium Delayed Release
- Imprint
- Logo 142
- Strength
- 125 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis
- National Drug Code (NDC)
- 00228-2142
Related images for "Logo 142"
More about divalproex sodium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (510)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Professional resources
- Divalproex Capsules prescribing information
- Divalproex Delayed Release (FDA)
- Divalproex Delayed Release Tablets (FDA)
- Divalproex Extended Release (FDA)
- Divalproex Sprinkle (FDA)
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.